Hester Biosciences surges up to 13% in a weak market. What’s fuelling the gain?
Meanwhile to manufacture additional quantities of the vaccine and to ensure the continuance of the manufacturing and the supply of all other vaccines against poultry, sheep, goat and cattle, Hester is undergoing capacity expansion. This capacity expansion would be completed in January 2023, the company said.